TapImmune signs new collaborative research agreement with VGTI Florida

[News]

TapImmune, Inc., is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida, a leading, non-profit biomedical research institute, forming a partnership to advance TapImmune's proprietary, cancer vaccines into Phase II human clinical trials for the treatment of breast and ovarian cancers.

More... (http://www.news-medical.net/news/20141118/TapImmune-signs-new-collaborative-research-agreement-with-VGTI-Florida.aspx)